Trial Profile
A multicenter retrospective study of octreotide in patients with left ventricular assist device related gastrointestinal bleeding
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Gastrointestinal haemorrhage
- Focus Therapeutic Use
- 09 May 2016 New trial record
- 30 Apr 2016 Results of preliminary analysis (n=34) presented at the 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation